抗真菌薬の世界市場2018-2022

◆英語タイトル:Global Antifungal Drugs Market 2018-2022
◆商品コード:IRTNTR23954
◆発行会社(リサーチ会社):Technavio
◆発行日:2018年12月13日
◆ページ数:97
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、抗真菌薬の世界市場について調査・分析し、市場概要、市場環境、抗真菌薬市場規模、投薬経路別(局所、経口)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・抗真菌薬の世界市場概要
・抗真菌薬の世界市場環境
・抗真菌薬の世界市場動向
・抗真菌薬の世界市場規模
・抗真菌薬の世界市場:業界構造分析
・抗真菌薬の世界市場:投薬経路別(局所、経口)
・抗真菌薬の世界市場:地域別市場規模・分析
・抗真菌薬の北米市場規模・予測
・抗真菌薬のヨーロッパ・中東・アフリカ市場規模・予測
・抗真菌薬のアジア太平洋市場規模・予測
・抗真菌薬の主要国分析
・抗真菌薬の世界市場:意思決定フレームワーク
・抗真菌薬の世界市場:成長要因、課題
・抗真菌薬の世界市場:競争環境
・抗真菌薬の世界市場:関連企業情報(ベンダー分析)

主な分析対象企業は、Astellas Pharma、Basilea Pharmaceutica、Merck、Pfizerなどです。
【レポートの概要】

About this market
Use of antifungal infections is expected to drive growth in the market. Research has shown synergism between many antifungals, which has led to an increase in clinicians prescribing combination therapies over monotherapies. Also, availability of antifungals with novel mechanisms of actions has promoted the trend of using combinations. Technavio’s analysts have predicted that the antifungal drugs market will register a CAGR of over 3% by 2022.
Market Overview
Increase in antifungal research funding
An increase in funding for antifungal research is another key factor contributing to the growth of the global antifungal drugs market. In many European countries, government funding is also available for research in fungal diseases.
Diagnostic challenges due to non-specific symptoms
Antifungals are often associated with mild adverse effects like itching, redness, abdominal pain, and diarrhea.
For the detailed list of factors that will drive and challenge the growth of the antifungal drugs market during the 2018-2022, view our report.
Competitive Landscape
The market appears to be fragmented and with the presence of several companies including Merck and Pfizer the competitive environment is quite intense. Factors such as the use of antifungal infections and the increase in antifungal research funding, will provide considerable growth opportunities to antifungal drugs manufactures. Astellas Pharma, Basilea Pharmaceutica, Merck, and Pfizer are some of the major companies covered in this report.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: PIPELINE ANALYSIS
• Fungal infection pipeline
PART 06: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 08: MARKET SEGMENTATION BY ROUTE OF ADMINISTRATION
• Segmentation by route of administration
• Comparison by route of administration
• Topical – Market size and forecast 2017-2022
• Oral – Market size and forecast 2017-2022
• Parenteral – Market size and forecast 2017-2022
• Market opportunity by product
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Vendors covered
PART 15: VENDOR ANALYSIS
• Market positioning of vendors
• Astellas Pharma
• Basilea Pharmaceutica
• Merck
• Pfizer
PART 16: APPENDIX
• List of abbreviations



Exhibit 01: Parent market
Exhibit 02: Global antifungals treatment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Late-stage pipeline drugs against fungal infections
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global antifungal drugs market – Market size and forecast 2017-2022 ($ mn)
Exhibit 10: Global antifungal drugs market – Year-over-year growth 2018-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition – Five forces 2017
Exhibit 19: Route of administration – Market share 2017-2022 (%)
Exhibit 20: Comparison by route of administration
Exhibit 21: Topical – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Topical – Year-over-year growth 2018-2022 (%)
Exhibit 23: Oral – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Oral – Year-over-year growth 2018-2022 (%)
Exhibit 25: Parenteral – Market size and forecast 2017-2022 ($ mn)
Exhibit 26: Parenteral – Year-over-year growth 2018-2022 (%)
Exhibit 27: Market opportunity by product
Exhibit 28: Customer landscape
Exhibit 29: Global antifungal drugs market – Market share by geography 2017-2022 (%)
Exhibit 30: Regional comparison
Exhibit 31: Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 32: Americas – Year-over-year growth 2018-2022 (%)
Exhibit 33: Top 3 countries in Americas
Exhibit 34: EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 35: EMEA – Year-over-year growth 2018-2022 (%)
Exhibit 36: Top 3 countries in EMEA
Exhibit 37: APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 38: APAC – Year-over-year growth 2018-2022 (%)
Exhibit 39: Top 3 countries in APAC
Exhibit 40: Market opportunity
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: Vendor overview
Exhibit 47: Astellas Pharma – Business segments
Exhibit 48: Astellas Pharma – Organizational developments
Exhibit 49: Astellas Pharma – Geographic focus
Exhibit 50: Astellas Pharma – Key offerings
Exhibit 51: Vendor overview
Exhibit 52: Basilea Pharmaceutica – Business segments
Exhibit 53: Basilea Pharmaceutica – Organizational developments
Exhibit 54: Basilea Pharmaceutica – Geographic focus
Exhibit 55: Basilea Pharmaceutica – Key offerings
Exhibit 56: Vendor overview
Exhibit 57: Merck – Business segments
Exhibit 58: Merck– Organizational developments
Exhibit 59: Merck – Geographic focus
Exhibit 60: Merck – Segment focus
Exhibit 61: Merck – Key offerings
Exhibit 62: Vendor overview
Exhibit 63: Pfizer – Business segments
Exhibit 64: Pfizer – Organizational developments
Exhibit 65: Pfizer – Geographic focus
Exhibit 66: Pfizer – Segment focus
Exhibit 67: Pfizer – Key offerings



【掲載企業】

Astellas Pharma、Basilea Pharmaceutica、Merck、Pfizer

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[抗真菌薬の世界市場2018-2022]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆